[seventy five] significant fees of Ozempic prompted some insurance plan companies to investigate and refuse to address people with what the companies considered was inadequate proof to support a diabetic issues diagnosis, alleging off-label prescribing for weight loss.[seventy six] * Ozempic and Victoza both of those Use a boxed warning through th